Earnings Feed
Start Free
Home/Filings/4/0001437749-22-013128
4//SEC Filing

Hahne Vicky 4

Accession 0001437749-22-013128

CIK 0001603454other
View on SEC.govCompany Profile

Filed

May 18, 8:00 PM ET

Accepted

May 19, 8:39 PM ET

Size

46.5 KB

Accession

0001437749-22-013128

Insider Transaction Report

Form 4
Period: 2022-05-17
Celcuity Inc.CELC
Hahne Vicky
Chief Financial Officer
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−3,806→ 0 total
    Exercise: $27.94Exp: 2031-04-12→ Common Stock (3,806 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+3,806→ 3,806 total
    Exercise: $5.50Exp: 2031-04-12→ Common Stock (3,806 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−3,000→ 0 total
    Exercise: $23.48Exp: 2028-07-05→ Common Stock (3,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−1,122→ 0 total
    Exercise: $10.35Exp: 2030-12-28→ Common Stock (1,122 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−1,301→ 0 total
    Exercise: $14.84Exp: 2031-02-02→ Common Stock (1,301 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+1,301→ 1,301 total
    Exercise: $5.50Exp: 2031-02-02→ Common Stock (1,301 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−1,204→ 0 total
    Exercise: $15.92Exp: 2031-03-18→ Common Stock (1,204 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+1,204→ 1,204 total
    Exercise: $5.50Exp: 2031-03-18→ Common Stock (1,204 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−15,000→ 0 total
    Exercise: $20.04Exp: 2031-08-11→ Common Stock (15,000 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+15,000→ 15,000 total
    Exercise: $5.50Exp: 2031-08-11→ Common Stock (15,000 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+821→ 821 total
    Exercise: $5.50Exp: 2031-10-27→ Common Stock (821 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+3,000→ 3,000 total
    Exercise: $5.50Exp: 2028-07-05→ Common Stock (3,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−932→ 0 total
    Exercise: $25.77Exp: 2028-10-17→ Common Stock (932 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+932→ 932 total
    Exercise: $5.50Exp: 2028-10-17→ Common Stock (932 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−3,000→ 0 total
    Exercise: $19.72Exp: 2029-08-12→ Common Stock (3,000 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+3,000→ 3,000 total
    Exercise: $5.50Exp: 2029-08-12→ Common Stock (3,000 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+1,122→ 1,122 total
    Exercise: $5.50Exp: 2030-12-28→ Common Stock (1,122 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−821→ 0 total
    Exercise: $17.19Exp: 2031-10-27→ Common Stock (821 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-05-17+31,930→ 31,930 total
    Exercise: $5.50Exp: 2032-05-17→ Common Stock (31,930 underlying)
Holdings

  • Common Stock

    12,903

  • Stock Option (right to buy)

    Exercise: $8.40Exp: 2027-05-17→ Common Stock (37,500 underlying)
    37,500

  • Stock Option (right to buy)

    Exercise: $5.90Exp: 2030-08-12→ Common Stock (10,000 underlying)
    10,000
Footnotes (14)
  • [F1]Includes 1,972 shares acquired on October 29, 2021 and 2,000 shares acquired on April 30, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
  • [F10]952 shares vest on 4/12/22; the remaining 2,854 shares vest 1/36th per month thereafter.
  • [F11]3,750 shares vest on 8/11/22; the remaining 11,250 shares vest 1/36th per month thereafter.
  • [F12]205 shares vest on 10/27/22; the remaining 616 shares vest 1/36th per month thereafter.
  • [F13]These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022.
  • [F14]The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option.
  • [F2]Fully vested.
  • [F3]750 shares vest on 7/5/19; the remaining 2,250 shares vest 1/36th per month thereafter.
  • [F4]233 shares vest on 10/17/19; the remaining 699 shares vest 1/36th per month thereafter.
  • [F5]750 shares vest on 8/12/20; the remaining 2,250 shares vest 1/36th per month thereafter.
  • [F6]2,500 shares vest on 8/12/21; the remaining 7,500 shares vest 1/36th per month thereafter.
  • [F7]280 shares vest on 12/29/21; the remaining 842 shares vest 1/36th per month thereafter.
  • [F8]325 shares vest on 2/2/22; the remaining 976 shares vest 1/36th per month thereafter.
  • [F9]301 shares vest on 3/18/22; the remaining 903 shares vest 1/36th per month thereafter.

Documents

1 file

Issuer

Celcuity Inc.

CIK 0001603454

→
Entity typeother

Related Parties

1
  • filerCIK 0001716043

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 8:39 PM ET
Size
46.5 KB
View on SEC.gov